Drugs / RN1201
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07113496 | Aug 2025 → Aug 2027 expected | B-cell acute lymphoblastic leukemia, plasma cell myeloma, plasmablastic lymphoma | The First Affiliated Hospital with Nanjing Medical University | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07105735 | Aug 2025 → Aug 2027 expected | — | The First Affiliated Hospital with Nanjing Medical University | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07114432 | Aug 2025 → Dec 2027 expected | plasma cell myeloma | Tianjin Medical University Cancer Institute and Hospital | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07652138 | Jul 2025 → Jan 2027 expected | plasma cell myeloma | The First Affiliated Hospital of Soochow University | Recruiting | No outcome recorded |
| Phase 1 | NCT07072247 | Jul 2025 → Jul 2026 overdue | autoimmune thrombocytopenia | The First Affiliated Hospital of Soochow University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RN1201 | “This single-arm, open-label exploratory trial aims to evaluate the safety, feasibility, and preliminary efficacy of RN1201 Injection in patients with antibody-mediated...” NCT07072247 ↗4“An Exploratory Clinical Study on the Safety and Efficacy of Allogeneic CAR-T Cell (RN1201) for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies” NCT07113496 ↗ “Eligible patients with moderate to severe activity of diseases will receive a single infusion of RN1201 following lymphodepletion.” NCT07105735 ↗ “Lymphodepletion chemotherapy followed by allogeneic CAR-T cell (RN1201) infusion” NCT07652138 ↗ “Lymphodepletion chemotherapy followed by allogeneic CAR-T cell (RN1201) infusion” NCT07114432 ↗ |
| Modality | Cell therapy | “RN1201, an Allogeneic CAR-T cell therapy” NCT07105735 ↗ |
| Route | Intravenous | “RN1201 cells injection will be infused only once intravenously at day 0” NCT07105735 ↗ |